In vitro branching tubulogenesis: Implications for developmental and cystic disorders, nephron number, renal repair, and nephron engineering

Kidney International

Volumn 54, Issue 1, 1998, Pages 14-26

  Sakurai, Hiroyuki ^a   Nigam, Sanjay K ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

Extracellular matrix; Growth factor; Integrin; Protease; Protease inhibitor; Three dimensional cell culture

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; INTEGRIN; PROTEINASE; SCATTER FACTOR; SCLEROPROTEIN; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR;

CELL MIGRATION; CELL PROLIFERATION; GENETIC ANALYSIS; HUMAN; IN VITRO STUDY; KIDNEY DEVELOPMENT; KIDNEY POLYCYSTIC DISEASE; MORPHOGENESIS; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TISSUE CULTURE;

EID: 0031807022     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00969.x     Document Type: Article

References (87)

1. SAXEN L: Organogenesis of the Kidney. Cambridge, Cambridge University Press, 1987
2. NIGAM SK, APERIA A, BRENNER BM: Development, maturation of the kidney, in The Kidney, edited by BRENNER BM, Saunders, Philadelphia, 1996
3. CAPECCHI MR: Altering the genome by homologous recombination. Science 244:1288-1292, 1989
4. CAPECCHI MR: Targeted gene replacement. Sci Am 270:52-59, 1994
5. GALLI-TALIADOROS LA, SEDGWICK JD, WOOD SA, KORNER H: Gene knock-out technology: A methodological overview for the interested novice. J Immunol Methods 181:1-15, 1995
6. BOYDEN EA: Experimental obstruction of the mesonephric ducts. Proc Soc Exp Biol Med 24:572-576, 1927
7. EKBLOM P, THESLEFF I, MIETTINEN A, SAXEN L: Organogenesis in a defined medium supplemented with transferrin. Cell Differ 10:281-288, 1981
8. BRIERE N: Human foetal kidney explants in serum-free organ culture. Anat Embryol (Berl) 176:105-114, 1987
9. DURBEEJ M, SODERSTROM S, EBENDAL T, BIRCHMEIER C, EKBLOM P: Differential expression of neurotrophin receptors during renal development. Development 119:977-989, 1993
10. MONTESANO R, SCHALLER G, ORCI L: Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors. Cell 66:697-711, 1991
11. SANTOS OF, NIGAM SK: HGF-induced tubulogenesis and branching of epithelial cells is modulated by extracellular matrix and TGF-beta. Dev Biol 160:293-302, 1993
12. SANTOS OF, MOURA LA, ROSEN EM, NIGAM SK: Modulation of HGF-induced tubulogenesis and branching by multiple phosphorylation mechanisms. Dev Biol 159:535-548, 1993
13. CANTLEY LG, BARROS EJ, GANDHI M, RAUCHMAN M, NIGAM SK: Regulation of mitogenesis, motogenesis, and tubulogenesis by hepatocyte growth factor in renal collecting duct cells. Am J Physiol 267:F271-F280, 1994
14. BARROS EJ, SANTOS OF, MATSUMOTO K, NAKAMURA T, NIGAM SK: Differential tubulogenic and branching morphogenetic activities of growth factors: Implications for epithelial tissue development. Proc Natl Acad Sci USA 92:4412-4416, 1995
15. SAKURAI H, TSUKAMOTO T, KJELSBERG CA, CANTLEY LG, NIGAM SK: EGF receptor ligands are a large fraction of in vitro branching morphogens secreted by embryonic kidney. Am J Physiol 273:F463-F472, 1997
16. SAKURAI H, BARROS EJ, TSUKAMOTO T, BARASCH J, NIGAM SK: An in vitro tubulogenesis system using cell lines derived from the embryonic kidney shows dependence on multiple soluble growth factors. Proc Natl Acad Sci USA 94:6279-6284, 1997
17. MONTESANO R, MATSUMOTO K, NAKAMURA T, ORCI L: Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67:901-908, 1991
18. SANTOS OF, BARROS EJ, YANG XM, MATSUMOTO K, NAKAMURA T, PARK M, NIGAM SK: Involvement of hepatocyte growth factor in kidney development. Dev Biol 163:525-529, 1994
19. BLADT F, RIETHMACHER D, ISENMANN S, AGUZZI A, BIRCHMEIER C: Essential role for c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature (Lond) 376:768-771, 1995
20. SCHMIDT C, BLADT F, GOEDECKE S, BRINKMANN V, ZSCHIESCHE W, SHARPE M, GHERARDI E, BIRCHMEIER C: Scatter factor/hepatocyte growth factor is essential for liver development. Nature (Lond) 373:699-702, 1995
21. KJELSBERG C, SAKURAI H, SPOKES K, BIRCHMEIER C, DRUMMOND I, NIGAM S, CANTLEY LG: Met -/- kidneys express epithelial cells that chemotax and form tubules in response to EGF receptor ligands. Am J Physiol 272:F222-F228, 1997
22. ROGERS SA, RYAN G, HAMMERMAN MR: Metanephric transforming growth factor alpha is required for renal organogenesis in vitro. Am J Physiol 262:F533-F539, 1992
23. MANN GB, FOWLER KJ, GABRIEL A, NICE EC, WILLIAMS RL, DUNN AR: Mice with a null mutation of TGFα gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 73:249-261, 1993
24. LUETTEKE NC, QUI TH, PEIFFER RL, OLIVER P, SMITHIES O, LEE DC: TGF-α deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 73:263-278, 1993
25. THREADGILL DW, DLUGOSZ AA, HANSEN LA, TENNENBAUM T, LICHTI U, YEE D, LAMANTIA C, MOURTON T, HERRUP K, HARRIS RC, BARNARD JA, YUSPA SH, COFFEY RJ, MAGNUSON T: Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype. Science (Wash DC) 269:230-234, 1995
26. ROGERS SA, RYAN G, HAMMERMAN MR: Insulin-like growth factors I and II are produced in metanephros and are required for growth and development in vitro. J Cell Biol 113:1447-1453, 1991
27. LIU ZZ, WADA J, ALVARES K, KUMAR A, WALLNER EI, KANWAR YS: Distribution and relevance of insulin-like growth factor-I receptor in metanephric development. Kidney Int 44:1242-1250, 1993
28. LIU JP, BAKER J, PERKINS AS, ROBERTSON EJ, EFSTRATIADIS A: Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72, 1993
29. BAKER J, LIU JP, ROBERTSON EJ, EFSTRATIADIS A: Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82, 1993
30. POWELL-BRAXTON L, HOLLINGSHEAD P, WARBURTON C, DOWD M, PITTS-MEEK S, DALTON D, GILLETT N, STEWART TA: IGF-I is required for normal embryonic growth in mice. Genes Dev 7:2609-2617, 1993
31. DURBEC P, MARCOS-GUTIERREZ CV, KILKENNY C, GRIGORIOU M, WARTIOWAARA K, SUVANTO P, SMITH D, PONDER B, COSTANTINI F, SAARMA M, ET AL: GDNF signalling through the Ret receptor tyrosine kinase. (see comments) Nature 381:789-793, 1996
32. JING S, WEN D, YU Y, HOLST PL, LUO Y, FANG M, TAMIR R, ANTONIO L, HU Z, CUPPLES R, LOUIS JC, HU S, ALTROCK BW, FOX GM: GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85: 1113-1124, 1996
33. VEGA QC, WORBY CA, LECHNER MS, DIXON JE, DRESSLER GR: Glial cell line-derived neurotrophic factor activates the receptor tyrosine kinase RET and promotes kidney morphogenesis. Proc Natl Acad Sci USA 93:10657-10661, 1996
34. WORBY CA, VEGA QC, ZHAO Y, CHAO HHJ, SEASHOLTZ AF, DIXON JE: Glial cell line-derived neurotrophic factor signals through the RET receptor and activates mitogen-activated protein kinase. J Biol Chem 271:23619-23622, 1996
35. SCHUCHARDT A, D'AGATI VD, PACHNIS V, COSTANTINI F: Renal agenesis and hypodysplasia in ret-k-mutant mice result from defects in ureteric bud development. Development 122:1919-1929, 1996
36. MOORE MW, KLEIN RD, FARINAS I, SAUER H, ARMANINI M, PHILLIPS H, REICHARDT LF, RYAN AM, CARVER-MOORE K, ROSENTHAL A: Renal and neuronal abnormalities in mice lacking GDNF. Nature 382:76-79, 1996
37. PICHEL JG, SHEN L, SHENG HZ, GRANHOLM AC, DRAGO J, GRINBERG A, LEE EJ, HUANG SP, SAARMA M, HOFFER BJ, SARIOLA H, WESTPHAL H: Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382:73-76, 1996
38. SANCHEZ MP, SILOS-SANTIAGO I, FRISEN J, HE B, LIRA SA, BARBACID M: Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382:70-73, 1996
39. PACHNIS V, MANKOO B, COSTANTINI F: Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119:1005-1017, 1993
40. HELLMICH HL, KOS L, CHO ES, MAHON KA, ZIMMER A: Embryonic expression of glial cell-line derived neurotrophic factor (GDNF) suggests multiple developmental roles in neural differentiation and epithelial-mesenchymal interactions. Mech Dev 54:95-105, 1996
41. CHEN JM, HELLER D, POON B, KANG L, WANG LH: The protooncogene c-ros codes for a transmembrane tyrosine protein kinase sharing sequence and structural homology with sevenless protein of Drosophila melanogaster. Oncogene 6:257-264, 1991
42. KANWAR YS, LIU ZZ, KUMAR A, WADA J, CARONE FA: Cloning of mouse c-ros renal cDNA, its role in development and relationship to extracellular matrix glycoproteins. Kidney Int 48:1646-1659, 1995
43. SONNENBERG-RIETHMACHER E, WALTER B, RIETHMACHER D, GoDECKE S, BIRCHMEIER C: The c-ros tyrosine kinase receptor controls regionalization and differentiation of epithelial cells in the epididymis. Genes Dev 10:1184-1193, 1996
44. KINGSLEY DM: The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133-146, 1994
45. MASSAGUE J: The transforming growth factor-beta family. Annu Rev Cell Biol 6:597-641, 1990
46. ROGERS SA, RYAN G, PURCHIO AF, HAMMERMAN MR: Metanephric transforming growth factor-β1 regulates nephrogenesis in vitro. Am J Physiol 264:F996-F1002, 1993
47. SAKURAI H, NIGAM SK: Transforming growth factor-beta selectively inhibits branching morphogenesis but not tubulogenesis. Am J Physiol 272:F139-F146, 1997
48. PELTON RW, SAXENA B, JONES M, MOSES HL, GOLD LI: Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development. J Cell Biol 115:1091-1105, 1991
49. SANFORD LP, ORMSBY I, GITTENBERGER-DE GROOT AC, SARIOLA H, FRIEDMAN R, BOIVIN GP, CARDELL EL, DOETSCHMAN T: TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124:2659-2670, 1997
50. RITVOS O, TUURI T, ERAMAA M, SAINIO K, HILDEN K, SAXEN L, GIEBERT SF: Activin disrupts epithelial branching morphogenesis in developing glandular organs of the mouse. Mech Dev 50:229-245, 1995
51. LUO G, HOFMANN C, BRONCKERS AL, SOHOCKI M, BRADLEY A, KARSENTY G: BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9:2808-2820, 1995
52. DUDLEY AT, LYONS KM, ROBERTSON EJ: A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9:2795-2807, 1995
53. CANTLEY LG, CANTLEY LC: Signal transduction by the hepatocyte growth factor receptor, c-met. Activation of the phosphatidylinositol 3-kinase. (Editorial) J Am Soc Nephrol 5:1872-1881, 1995
54. CANTLEY LG: Growth factors and the kidney: Regulation of epithelial cell movement and morphogenesis. Am J Physiol 271:F1103-F1113, 1996
55. WEIDNER KM, DI CESARE S, SACHS M, BRINKMANN V, BEHRENS J, BIRCHMEIER W: Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature 384:173-176, 1996
56. HOLGADO-MADRUGA M, EMLET DR, MOSCATELLO DK, GODWIN AK, WONG AJ: A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 379:560-564, 1996
57. POLLACK AL, BARTH AIM, ALTSCHULER Y, NELSON WJ, MOSTOV KE: Dynamics of beta-catenin interactions with APC protein regulate epithelial tubulogenesis. J Cell Biol 137:1651-1662, 1997
58. CREPALDI T, GAUTREAU A, COMOGLIO PM, LOUVARD D, ARPIN M: Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells. J Cell Biol 138:423-434, 1997
59. SHIBAMOTO S, HAYAKAWA M, TAKEUCHI K, HORI T, OKU N, MIYAZAWA K, KITAMURA N, TAKEICHI M, ITO F: Tyrosine phosphorylation of beta-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes Commun 1:295-305, 1994
60. JIANG WG, HISCOX S, SINGHRAO SK, PUNTIS MC, NAKAMURA T, MANSEL RE, HALLETT MB: Induction of tyrosine phosphorylation and translocation of ezrin by hepatocyte growth factor/scatter factor. Biochem Biophys Res Commun 217:1062-1069, 1995
61. STUART RO, BARROS EJ, RIBEIRO E, NIGAM SK: Epithelial tubulogenesis through branching morphogenesis: Relevance to collecting system development. (Editorial) J Am Soc Nephrol 6:1151-1159, 1995
62. LELONGT B, TRUGNAN G, MURPHY G, RONCO PM: Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro. J Cell Biol 136:1363-1373, 1997
63. Deleted in proof.
64. Deleted in proof.
65. PLATT JL, BROWN DM, GRANLUND K, OEGEMA TR, KLEIN DJ: Proteoglycan metabolism associated with mouse metanephric development: Morphologic and biochemical effects of beta-D-xyloside. Dev Biol 123:293-306, 1987
66. LELONGT B, MAKINO H, DALECKI TM, KANWAR YS: Role of proteoglycans in renal development. Dev Biol 128:256-276, 1988
67. KISPERT A, VAINIO S, SHEN L, ROWITCH DH, MCMAHON AP: Proteoglycans are required for maintenance of Wnt-11 expression in the ureter tips. Development 122:3627-3637, 1996
68. Deleted in proof.
69. KREIDBERG JA, DONOVAN MJ, GOLDSTEIN SL, RENNKE H, SHEPHERD K, JONES RC, JAENISCH R: Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development 122:3537-3547, 1996
70. SAELMAN EU, KEELY PJ, SANTORO SA: Loss of MDCK cell alpha 2 beta 1 integrin expression results in reduced cyst formation, failure of hepatocyte growth factor/scatter factor-induced branching morphogenesis, and increased apoptosis. J Cell Sci 108:3531-3540, 1995
71. MULLER U, WANG D, DENDA S, MENESES JJ, PEDERSEN RA, REICHARDT LF: Integrin alpha8beta1 is critically important for epithelial-mesenchymal interactions during kidney morphogenesis. Cell 88:603-613, 1997
72. BURK D, BHAUDOIN AR: Arsenate-induced renal agenesis in rats. Teratology 16:247-259, 1977
73. MACKENZIE HS, LAWLER EV, BRENNER BM: Congenital oligonephropathy: The fetal flaw in essential hypertension? Kidney Int 49(Suppl 55):S30-S34, 1996
74. BRENNER BM, CHERTOW GM: Congenital oligonephropathy: An inborn cause of adult hypertension and progressive renal injury? Curr Opin Nephrol Hypertens 2:691-695, 1993
75. AZUMA H, NADEAU K, MACKENZIE HS, BRENNER BM, TILNEY NL: Nephron mass modulates the hemodynamic, cellular, and molecular response of the rat renal allograft. Transplantation 63:519-528, 1997
76. CARONE FA, BACALLAO R, KANWAR YS: Biology of polycystic kidney disease. Lab Invest 70:437-448, 1994
77. THE INTERNATIONAL POLYCYSTIC KIDNEY DISEASE CONSORTIUM: Polycystic kidney disease: The complete structure of the PKD1 gene and its protein. Cell 81:289-298, 1995
78. IGAWA T, MATSUMOTO K, KANDA S, SAITO Y, NAKAMURA T: Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am J Physiol 265:F61-F69, 1993
79. HOMMA T, SAKAI M, CHENG HF, YASUDA T, COFFEY RJ JR, HARRIS RC: Induction of heparin-binding epidermal growth factor-like growth factor mRNA in rat kidney after acute injury. J Clin Invest 96:1018-1025, 1995
80. MILLER SB, MARTIN DR, KISSANE J, HAMMERMAN MR: Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am J Physiol 266:F129-F134, 1994
81. KAWAIDA K, MATSUMOTO K, SHIMAZU H, NAKAMURA T: Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA 91:4357-4361, 1994
82. COIMBRA TM, CIESLINSKI DA, HUMES HD: Epidermal growth factor accelerates renal repair in mercuric chloride nephrotoxicity. Am J Physiol 259:F438-F443, 1990
83. HUMES HD, CIESLINSKI DA, COIMBRA TM, MESSANA JM, GALVAO C: Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J Clin Invest 84:1757-1761, 1989
84. MILLER SB, MARTIN DR, KISSANE J, HAMMERMAN MR: Rat models for clinical use of insulin-like growth factor I in acute renal failure. Am J Physiol 266:F949-F956, 1994
85. BORDER WA, NOBLE NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
86. BASILE DP, ROVAK JM, MARTIN DR, HAMMERMAN MR: Increased transforming growth factor-beta 1 expression in regenerating rat renal tubules following ischemic injury. Am J Physiol 270:F500-F509, 1996
87. NIGAM SK: Determinants of branching tubulogenesis. Curr Opin Nephrol Hypertens 4:209-214, 1995